Baird Financial Group, Inc. Invitae Corp Transaction History

Baird Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.72 $2,471 - $4,236	-5,884 Reduced 5.07%	110,100 $69,000
Q3 2023 Nov 13, 2023	BUY	$0.6 - $1.53 $69,590 - $177,455	115,984 New	115,984 $69,000
Q4 2021 Feb 09, 2022	SELL	$14.7 - $28.67 $917,750 - $1.79 Million	-62,432 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $685,444 - $947,385	28,196 Added 82.36%	62,432 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $400,903 - $1.04 Million	34,236 New	34,236 $588,000

Q1 2020 May 14, 2020	SELL	$7.64 - $27.5 $253,793 - $913,522	-33,219 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.02 - $20.57 $4,911 - $6,726	327 Added 0.99%	33,219 $536,000
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $620,014 - $904,530	32,892 New	32,892 $634,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.